Date: February 5, 2009
Source: Stericycle Inc.
Stericycle, Inc. (NASDAQ: SRCL), today reported financial results for the fourth quarter of 2008.
Revenues for the quarter ended December 31, 2008 were $274.0 million, up 8.9% from $251.6 million in the same quarter last year. Acquisitions less than 12 months old contributed approximately $14.2 million to the growth in revenues for the quarter. Gross profit was $125.3 million, up 11.5% from $112.4 million in the same quarter last year. Gross profit as a percent of revenue was 45.7% versus 44.7% in the fourth quarter of 2007.
Net income for the fourth quarter of 2008 was $39.1 million or $0.45 per diluted share compared with net income of $24.1 million or $0.27 per diluted share for the fourth quarter of 2007. Net income for the fourth quarter of 2007 included the effect of $9.8 million of charges or $0.11 per diluted share related to an arbitration settlement, trade name write-down and foreign investment write-down. These charges were partially offset by receipt of insurance proceeds and a gain on sale of assets.
FULL YEAR RESULTS
For the full year ended December 31, 2008, revenues were $1.1 billion, up 16.2% from $932.8 million in the same period last year. Gross profit was $485.0 million, up 16.1% from $417.9 million in the same period last year. Gross profit as a percent of revenues was 44.8% in both 2008 and 2007. Earnings per diluted share for 2008 increased 27.9% to $1.68 from $1.32 per diluted share for 2007. Earnings per diluted share for 2008 were negatively impacted by $0.05 per diluted share related to the arbitration settlement recorded in the first quarter of 2008 and impairment of fixed assets. Earnings per diluted share for 2007 were negatively impacted by $9.3 million of charges or $0.10 per diluted share for the impairment of permit, fixed assets write-offs and the charges described in the quarterly results paragraph above, partially offset by the receipt of insurance proceed and gains from sale of assets.
Cash flow from operations was $210.6 million for the full year of 2008. Cash flow and increased loan balances were used to strengthen our business by acquisitions, international investments, capital expenditures and funding share repurchases.
For more information about Stericycle, please visit our website at www.stericycle.com.
Conference call to be held February 5, 2009 at 4:00 p.m. Central time – Dial 866-516-6872 at least 5 minutes before start time. If you are unable to participate on the call, a replay will be available through March 5th by dialing 800-642-1687, access code 79888607. To hear a live simulcast of the call over the internet on www.earnings.com, or to access an audio archive of the call, go to the Investors page on Stericycle’s website at www.stericycle.com.
Safe Harbor Statement: Statements in this press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of medical waste collection and treatment and increases in transportation and other operating costs, as well as the other factors described in our filings with the U.S. Securities and Exchange Commission. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.
STERICYCLE, INC. AND SUBSIDIARIES | |||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
(IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA) | |||||||
December 31, | December 31, | ||||||
2008 | 2007 | ||||||
(unaudited) | (audited) | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 9,095 | $ | 17,108 | |||
Short-term investments | 1,408 | 1,256 | |||||
Accounts receivable, less allowance for doubtful | |||||||
accounts of $6,616 in 2008 and $6,157 in 2007 | 168,598 | 157,435 | |||||
Deferred income taxes | 16,821 | 13,510 | |||||
Other current assets | 28,508 | 20,967 | |||||
Total current assets | 224,430 | 210,276 | |||||
Property, plant and equipment, net | 207,144 | 193,039 | |||||
Other assets: | |||||||
Goodwill | 1,136,843 | 1,033,333 | |||||
Intangible assets, less accumulated amortization of | |||||||
$14,116 in 2008 and $12,230 in 2007 | 168,849 | 152,689 | |||||
Other | 21,322 | 18,822 | |||||
Total other assets | 1,327,014 | 1,204,844 | |||||
Total assets | $ | 1,758,588 | $ | 1,608,159 | |||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Current portion of long-term debt | $ | 38,880 | $ | 22,003 | |||
Accounts payable | 33,612 | 40,049 | |||||
Accrued liabilities | 93,487 | 75,571 | |||||
Deferred revenues | 13,663 | 12,095 | |||||
Total current liabilities | 179,642 | 149,718 | |||||
Long-term debt, net of current portion | 753,846 | 613,781 | |||||
Deferred income taxes | 146,577 | 125,041 | |||||
Other liabilities | 8,043 | 5,544 | |||||
Shareholders' equity: | |||||||
Common stock (par value $0.01 per share, 120,000,000 shares | |||||||
authorized, 85,252,879 issued and outstanding in 2008, | |||||||
87,410,653 issued and outstanding in 2007) | 852 | 874 | |||||
Additional paid-in capital | 67,776 | 197,462 | |||||
Accumulated other comprehensive income | (32,075 | ) | 30,520 | ||||
Retained earnings | 633,927 | 485,219 | |||||
Total shareholders' equity | 670,480 | 714,075 | |||||
Total liabilities and shareholders' equity | $ | 1,758,588 | $ | 1,608,159 |
STERICYCLE, INC. AND SUBSIDIARIES | ||||||||||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||||||||||
(IN THOUSANDS EXCEPT FOR SHARE AND PER SHARE DATA) | ||||||||||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||
(unaudited) | (unaudited) | (audited) | ||||||||||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||||||||||
$ | % of Rev | $ | % of Rev | $ | % of Rev | $ | % of Rev | |||||||||||||||||
Revenues | $ | 274,011 | 100.0 | % | $ | 251,550 | 100.0 | % | $ | 1,083,679 | 100.0 | % | $ | 932,767 | 100.0 | % | ||||||||
Cost of revenues | 148,755 | 54.3 | % | 139,196 | 55.3 | % | 598,650 | 55.2 | % | 514,846 | 55.2 | % | ||||||||||||
Gross profit | 125,256 | 45.7 | % | 112,354 | 44.7 | % | 485,029 | 44.8 | % | 417,921 | 44.8 | % | ||||||||||||
Selling, general and | ||||||||||||||||||||||||
administrative expenses | 51,098 | 18.6 | % | 48,369 | 19.2 | % | 199,171 | 18.4 | % | 173,080 | 18.6 | % | ||||||||||||
Amortization | 1,095 | 0.4 | % | 978 | 0.4 | % | 4,039 | 0.4 | % | 3,657 | 0.4 | % | ||||||||||||
Total SG&A expense and amortization | 52,193 | 19.0 | % | 49,347 | 19.6 | % | 203,210 | 18.8 | % | 176,737 | 18.9 | % | ||||||||||||
Income from operations before acquisition integration and other expenses | 73,063 | 26.7 | % | 63,007 | 25.0 | % | 281,819 | 26.0 | % | 241,184 | 25.9 | % | ||||||||||||
Gain on sale of assets | - | 0.0 | % | (201 | ) | -0.1 | % | - | 0.0 | % | (2,099 | ) | -0.2 | % | ||||||||||
Impairment of intangible assets | - | 0.0 | % | 2,041 | 0.8 | % | - | 0.0 | % | 2,269 | 0.2 | % | ||||||||||||
Impairment of fixed assets | 472 | 0.2 | % | - | 0.0 | % | 472 | 0.0 | % | 1,261 | 0.1 | % | ||||||||||||
Arbitration settlement and related costs | - | 0.0 | % | 13,904 | 5.5 | % | 5,595 | 0.5 | % | 13,904 | 1.5 | % | ||||||||||||
Acquisition integration expenses | 274 | 0.1 | % | 26 | 0.0 | % | 1,513 | 0.1 | % | 1,305 | 0.1 | % | ||||||||||||
Income from operations | 72,317 | 26.4 | % | 47,237 | 18.8 | % | 274,239 | 25.3 | % | 224,544 | 24.1 | % | ||||||||||||
Other income (expense): | ||||||||||||||||||||||||
Interest Income | 186 | 0.1 | % | 345 | 0.1 | % | 930 | 0.1 | % | 1,590 | 0.2 | % | ||||||||||||
Interest expense | (8,219 | ) | -3.0 | % | (9,125 | ) | -3.6 | % | (33,104 | ) | -3.1 | % | (33,965 | ) | -3.6 | % | ||||||||
Write-down of investment | - | 0.0 | % | (2,930 | ) | -1.2 | % | - | 0.0 | % | (2,930 | ) | -0.3 | % | ||||||||||
Insurance proceeds | - | 0.0 | % | 2,800 | 1.1 | % | - | 0.0 | % | 3,300 | 0.4 | % | ||||||||||||
Other expense, net | (1,489 | ) | -0.5 | % | (269 | ) | -0.1 | % | (3,061 | ) | -0.3 | % | (1,299 | ) | -0.1 | % | ||||||||
Total other income (expense) | (9,522 | ) | -3.5 | % | (9,179 | ) | -3.6 | % | (35,235 | ) | -3.3 | % | (33,304 | ) | -3.6 | % | ||||||||
Income before income taxes | 62,795 | 22.9 | % | 38,058 | 15.1 | % | 239,004 | 22.1 | % | 191,240 | 20.5 | % | ||||||||||||
Income tax expense | 23,663 | 8.6 | % | 13,960 | 5.5 | % | 90,296 | 8.3 | % | 72,862 | 7.8 | % | ||||||||||||
Net income | $ | 39,132 | 14.3 | % | $ | 24,098 | 9.6 | % | $ | 148,708 | 13.7 | % | $ | 118,378 | 12.7 | % | ||||||||
Earnings per share-diluted | $ | 0.45 | $ | 0.27 | $ | 1.68 | $ | 1.32 | ||||||||||||||||
Weighted average number of | ||||||||||||||||||||||||
common shares outstanding-diluted | 87,634,578 | 89,801,677 | 88,347,421 | 89,933,242 |
STERICYCLE, INC. AND SUBSIDIARIES | ||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
(IN THOUSANDS) | ||||||||
For the Year Ended | ||||||||
December 31, | ||||||||
2008 | 2007 | |||||||
(unaudited) | (audited) | |||||||
Operating Activities: | ||||||||
Net income | $ | 148,708 | $ | 118,378 | ||||
Adjustments to reconcile net income to net cash | ||||||||
provided by operating activities: | ||||||||
Gain on sale of assets | - | (2,099 | ) | |||||
Loss on sale and impairment of fixed assets | 472 | 1,261 | ||||||
Impairment of intangibles | - | 2,269 | ||||||
Write-down of investment | - | 2,930 | ||||||
Write-off of note receivable related to joint venture | 798 | - | ||||||
Stock compensation expense | 11,755 | 10,714 | ||||||
Excess tax benefit of stock options exercised | (9,319 | ) | (8,054 | ) | ||||
Depreciation | 30,109 | 27,480 | ||||||
Amortization | 4,039 | 3,657 | ||||||
Deferred income taxes | 26,522 | 17,265 | ||||||
Changes in operating assets and liabilities, net of | ||||||||
effect of acquisitions and divestitures: | ||||||||
Accounts receivable | (12,998 | ) | (11,400 | ) | ||||
Accounts payable | (7,041 | ) | 6,987 | |||||
Accrued liabilities | 19,517 | 1,566 | ||||||
Deferred revenues | 1,597 | 537 | ||||||
Other assets | (3,604 | ) | 2,551 | |||||
Net cash provided by operating activities | 210,555 | 174,042 | ||||||
Investing Activities: | ||||||||
Payments for acquisitions and international | ||||||||
investments, net of cash acquired | (84,947 | ) | (114,781 | ) | ||||
Proceeds from maturity of short-term investments | (463 | ) | 1,301 | |||||
Proceeds from sale of assets | - | 26,616 | ||||||
Capital expenditures | (47,520 | ) | (48,397 | ) | ||||
Net cash used in investing activities | (132,930 | ) | (135,261 | ) | ||||
Financing Activities: | ||||||||
Repayment of long-term debt | (13,866 | ) | (30,447 | ) | ||||
Net (payments)/ proceeds on senior credit facility | (23,073 | ) | 77,686 | |||||
Proceeds from private placement of long-term note | 100,000 | - | ||||||
Payments of deferred financing costs | (236 | ) | (606 | ) | ||||
Net payments on capital lease obligations | (527 | ) | (212 | ) | ||||
Purchase/ cancellation of treasury stock | (167,338 | ) | (103,679 | ) | ||||
Proceeds from other issuances of common stock | 17,839 | 16,569 | ||||||
Excess tax benefit of stock options exercised | 9,319 | 8,054 | ||||||
Net cash used in financing activities | (77,882 | ) | (32,635 | ) | ||||
Effect of exchange rate changes on cash | (7,756 | ) | (2,530 | ) | ||||
Net (decrease)/ increase in cash and cash equivalents | (8,013 | ) | 3,616 | |||||
Cash and cash equivalents at beginning of period | 17,108 | 13,492 | ||||||
Cash and cash equivalents at end of period | $ | 9,095 | $ | 17,108 | ||||
Non-cash activities: | ||||||||
Net issuances of notes payable for certain acquisitions | $ | 106,074 | $ | 112,509 | ||||
Net issuances of common stock for certain acquisitions | - | 13,667 |
Sign up to receive our free Weekly News Bulletin